LeMaitre Vascular Total Assets 2007-2020 | LMAT

LeMaitre Vascular total assets from 2007 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
LeMaitre Vascular Annual Total Assets
(Millions of US $)
2019 $188
2018 $153
2017 $126
2016 $102
2015 $91
2014 $81
2013 $70
2012 $63
2011 $60
2010 $63
2009 $57
2008 $54
2007 $61
2006 $57
2005 $25
LeMaitre Vascular Quarterly Total Assets
(Millions of US $)
2020-06-30 $256
2020-03-31 $185
2019-12-31 $188
2019-09-30 $170
2019-06-30 $163
2019-03-31 $160
2018-12-31 $153
2018-09-30 $144
2018-06-30 $137
2018-03-31 $129
2017-12-31 $126
2017-09-30 $121
2017-06-30 $112
2017-03-31 $107
2016-12-31 $102
2016-09-30 $101
2016-06-30 $96
2016-03-31 $93
2015-12-31 $91
2015-09-30 $87
2015-06-30 $83
2015-03-31 $80
2014-12-31 $81
2014-09-30 $84
2014-06-30 $81
2014-03-31 $69
2013-12-31 $70
2013-09-30 $67
2013-06-30 $64
2013-03-31 $63
2012-12-31 $63
2012-09-30 $61
2012-06-30 $60
2012-03-31 $59
2011-12-31 $60
2011-09-30 $63
2011-06-30 $62
2011-03-31 $61
2010-12-31 $63
2010-09-30 $61
2010-06-30 $58
2010-03-31 $57
2009-12-31 $57
2009-09-30 $56
2009-06-30 $54
2009-03-31 $51
2008-12-31 $54
2008-09-30 $54
2008-06-30 $56
2008-03-31 $57
2007-12-31 $61
2007-09-30 $57
2007-06-30 $56
2007-03-31 $56
2006-12-31 $57
2006-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.650B $0.117B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $187.588B 35.20
Medtronic (MDT) Ireland $140.874B 26.53
Stryker (SYK) United States $76.056B 29.49
Boston Scientific (BSX) United States $55.153B 31.86
Lonza Group Ag (LZAGY) Switzerland $46.893B 0.00
Baxter (BAX) United States $40.625B 24.85
Terumo (TRUMY) Japan $30.404B 38.86
EssilorLuxottica Societe Anonyme (ESLOY) France $28.134B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.745B 23.02
ResMed (RMD) United States $24.852B 36.03
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.462B 0.00
Bio-Rad Laboratories (BIO) United States $15.371B 69.52
Insulet (PODD) United States $14.743B 623.81
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.390B 44.44
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.267B 10.75
Canopy Growth (CGC) Canada $5.852B 0.00
Hill-Rom Holdings (HRC) United States $5.626B 13.96
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.515B 0.00
Haemonetics (HAE) United States $4.236B 28.23
ICU Medical (ICUI) United States $4.018B 30.66
Neogen (NEOG) United States $3.955B 65.99
Envista Holdings (NVST) United States $3.743B 25.52
Abcam (ABCZY) $3.232B 0.00
TG Therapeutics (TGTX) United States $3.227B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.107B 0.00
National Vision Holdings (EYE) United States $3.004B 466.88
NuVasive (NUVA) United States $2.537B 35.36
Agios Pharmaceuticals (AGIO) United States $2.521B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.901B 173.46
AtriCure (ATRC) United States $1.737B 0.00
NanoString Technologies (NSTG) United States $1.723B 0.00
MacroGenics (MGNX) United States $1.489B 0.00
Cardiovascular Systems (CSII) United States $1.367B 0.00
Aphria (APHA) Canada $1.280B 0.00
InMode (INMD) Israel $1.113B 28.07
Cerus (CERS) United States $1.029B 0.00
Quanterix (QTRX) United States $0.941B 0.00
Owens & Minor (OMI) United States $0.906B 20.30
OraSure Technologies (OSUR) United States $0.905B 0.00
PetIQ (PETQ) United States $0.851B 24.41
BioLife Solutions (BLFS) United States $0.845B 440.00
Lantheus Holdings (LNTH) United States $0.833B 11.55
Meridian Bioscience (VIVO) United States $0.743B 17.16
Aurora Cannabis (ACB) Canada $0.730B 0.00
Phibro Animal Health (PAHC) United States $0.714B 16.35
Vapotherm (VAPO) United States $0.712B 0.00
Omeros (OMER) United States $0.636B 0.00
Zynex (ZYXI) United States $0.560B 48.91
Eagle Pharmaceuticals (EGRX) United States $0.540B 76.31
Surmodics (SRDX) United States $0.525B 57.61
VAREX IMAGING (VREX) United States $0.461B 19.99
Cytosorbents (CTSO) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.358B 12.79
HEXO (HEXO) $0.343B 0.00
Utah Medical Products (UTMD) United States $0.287B 24.64
Surface Oncology (SURF) United States $0.271B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
InfuSystems Holdings (INFU) United States $0.260B 49.54
Organigram Holdings (OGI) Canada $0.231B 0.00
Female Health (VERU) United States $0.197B 0.00
Chimerix (CMRX) United States $0.180B 0.00
Wound Management Technologies (SMTI) United States $0.172B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.155B 13.76
Exagen (XGN) United States $0.140B 0.00
Liberty Health Sciences (LHSIF) Canada $0.134B 0.00
Evolus (EOLS) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.102B 0.00
Rockwell Medical (RMTI) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.096B 0.00
United-Guardian (UG) United States $0.069B 15.46
Oramed Pharmaceuticals (ORMP) United States $0.066B 0.00
Brainsway (BWAY) Israel $0.064B 0.00
Nephros (NEPH) United States $0.057B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 9.95
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.034B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.021B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
NF Energy Saving (BIMI) China $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00